⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CERO News
CERo Therapeutics Holdings, Inc. Common Stock
Form 8-K
sec.gov
CERO
CEROW
Form 8-K
sec.gov
SXTPW
SXTP
CERO
SCYX
CERo Therapeutics Completes Second Ascending Dose Cohort of Phase 1 CER-1236 Trial
globenewswire.com
CERO
Form 8-K
sec.gov
CERO
CEROW
Form 8-K
sec.gov
CEROW
CERO
CERo Therapeutics Doses Third Patient in Cohort 2 of Phase 1 CER-1236 Trial
globenewswire.com
CERO
CERo Therapeutics Doses Second Patient in Cohort 2 of Phase 1 CER-1236 Trial
globenewswire.com
CERO
CERo Therapeutics Provides Shareholder Update
globenewswire.com
CERO
Form 8-K
sec.gov
CERO
CEROW
CERo Therapeutics to Present Late-Breaking Oral Poster Session Highlighting Interim Phase 1 Data from CERTAIN-T Trial Highlighting Platelet Transfusion Independence in a High-Risk MDS/AML Patient
globenewswire.com
CERO